Inactive Instrument

News Dyax Corp.

Stocks

US26746E1038

Biotechnology & Medical Research

End-of-day quote Nasdaq
- ^USD	-

15-11-24	Baxalta : Exclusive: Shire prepares to make new bid for Baxalta - source	RE
15-11-02	Wall St. climbs, led by energy, healthcare; Nasdaq 100 hits 15-year high	RE

All News

Mentions Relevance

16-01-22	Dyax : Shire Completes Acquisition of Dyax	PR
15-12-11	Dyax : Sets January 21, 2016 As Date of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Shire plc	BU
15-12-08	Dyax : Presents DX-4012 Data at the 2015 American Society of Hematology Annual Meeting	PU
15-12-08	Dyax : Announces Early Termination of Hart-Scott-Rodino Waiting Period	PU
15-12-08	Dyax : Recognized as a "Top Place to Work" by The Boston Globe for Second Year in a Row	PU
15-12-08	Dyax : Presents Phase 1b DX-2930 Data at the American College of Allergy, Asthma, and Immunology Annual Meeting	PU
15-12-06	Dyax : Presents DX-4012 Data at the 2015 American Society of Hematology Annual Meeting	BU
15-12-02	Dyax : Announces Early Termination of Hart-Scott-Rodino Waiting Period	BU
15-11-17	Dyax : Recognized as a “Top Place to Work” by The Boston Globe for Second Year in a Row	BU
15-11-11	DYAX : The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Dyax Corp. Concerning the Sale of the Company to Shire plc -- DYAX	PR
15-11-10	DYAX : Rigrodsky & Long, P.A. Announces Investigation Of Buyout	BU
15-11-09	Dyax : Levi & Korsinsky, LLP Notifies Shareholders of Dyax Corp. That It Has Commenced an Investigation Challenging the Fairness of the Sale of the Company to Shire plc	BU
15-11-09	Dyax : Presents Phase 1b DX-2930 Data at the American College of Allergy, Asthma, and Immunology Annual Meeting	BU
15-11-06	Dyax : Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information	BU
15-11-04	Dyax : Levi & Korsinsky, LLP Notifies Shareholders of Dyax Corp. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to Shire plc -- DYAX	BU
15-11-03	Dyax : Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information	BU
15-11-03	Dyax : Ryan & Maniskas, LLP : Announces Investigation of Dyax Corp.	PR
15-11-02	Dyax : Announces Cancellation of Research and Development Day	BU
15-11-02	Dyax : Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio	PR
15-10-28	Dyax : Announces Third Quarter 2015 Financial Results	BU
15-10-27	Dyax : to Review Third Quarter 2015 Financial Results at Research and Development Day	BU
15-10-26	Dyax : to Webcast 2015 Research and Development Day	BU
15-10-14	Dyax : to Host Third Quarter 2015 Financial Results Call and Webcast	BU
15-09-30	Dyax : Receives Positive Opinion for Orphan Medicinal Product Designation in the European Union for DX-2930 for the Treatment of Hereditary Angioedema	BU
15-09-22	Dyax : to Participate in the Leerink Partners 4th Annual Rare Disease Roundtable	BU